Table 3 The mother-to-child transmission rates and the serum HBV DNA recovery of the mothers at 28 weeks postpartum.
TDF treatment | Control | value | p | |||
|---|---|---|---|---|---|---|
Cases (n) | % | Cases (n) | % | |||
Mother-to-child Transmission | 8.338 | 0.004 | ||||
Occurred | 0 | 0% | 7 | 13.5% | ||
Did not occur | 59 | 100% | 45 | 86.5% | ||
Serum HBV DNA 28 weeks postpartum | 21.916 | 0.000003 | ||||
≤2000 IU/mL | 20 | 33.9% | 0 | 0% | ||
Recovery to the original level | 39 | 66.1% | 52 | 100% | ||
